
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
ALNYLAM PHARMACE.DL-,0001 DUL US02043Q1076
AB/FROM ONWARDS 21.03.2025 12:09 CET
© 2025 Xetra Newsboard
Realtime | Geld | Brief | Zeit |
---|---|---|---|
204,80 | 207,70 | 17.04. | |
204,60 | 207,70 | 17.04. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
04.04. | Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks | ||
04.04. | Canaccord maintains $390 target on Alnylam stock with Buy rating | ||
03.04. | H.C. Wainwright maintains $500 target on Alnylam stock | ||
01.04. | 27 Analysts Assess Alnylam Pharmaceuticals: What You Need To Know | ||
31.03. | Stifel cuts Alnylam stock price target to $300 from $345 |
Unternehmen / Aktien | Kurs | % |
---|---|---|
ALNYLAM PHARMACEUTICALS INC | 203,30 | -1,41 % |